NINDS Moyamoya Disease Information Page: NINDS
Article title: NINDS Moyamoya Disease Information Page: NINDS
Main condition: Moyamoya disease
Conditions: Moyamoya disease
What is Moyamoya Disease?
Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing or occlusion of major blood vessels leading into the brain, and the formation of abnormal blood vessels called moyamoya vessels. First described in Japan in the 1960’s, the disease has since been found in the United States, Europe, Australia, and Africa. It primarily affects children, adolescents, and young adults, although it has also been seen in people beyond these ages. Females are more frequently affected than males. The cause of the disease is unknown. Researchers suspect a genetic link because of the 9 percent incidence of the disease found in certain Japanese families. A gene for familial moyamoya disease has been located on chromosome 17q25 and further study of the gene may reveal the cause of the disorder. The name “moyamoya” is Japanese for “cloud of smoke” and was chosen to describe the classic appearance of the abnormal vessels seen in diagnostic tests. Children often present with stroke or recurrent transient ischemic attacks (TIAs), frequently accompanied by hemiparesis (muscular weakness or paralysis affecting one side of the body) or seizures. Adults most often experience stroke (often a hemorrhage). Both children and adults may have disturbed consciousness, speech deficits (aphasia), sensory and cognitive impairments, involuntary movements, and vision problems. Generally, cerebral angiography—a procedure that involves injecting dye into the cerebral arteries before taking an x-ray to make the arteries easier to see—is used to diagnose moyamoya disease.
Is there any
treatment?
There is no cure for moyamoya disease. Treatment is
symptomatic and supportive. Individuals experiencing TIAs and stroke may
be given aspirin, vasodilators, or anticoagulants to reduce the risk of
future attacks. There are several different types of revascularization
(restoration of blood supply) surgery that may be performed in some cases.
Children usually respond better to revascularization surgery than adults.
What is the
prognosis?
Progressive deterioration of cognitive function is seen
in the majority of individuals with moyamoya disease. Death usually
results from intracerebral hemorrhage.
What research is being
done?
Within the NINDS research programs, moyamoya disease is
addressed primarily through studies associated with TIA and stroke. NINDS
is the leading supporter of research on stroke and TIA in the United
States and sponsors studies ranging from clinical trials to investigations
of basic biological mechanisms.
National Rehabilitation Information Center (NARIC)
1010 Wayne
Avenue
Suite 800
Silver Spring, MD 20910-5633
naricinfo@kra.com
http://www.naric.com/
Tel:
301-562-2400 800-346-2742
Fax: 301-562-2401
National Organization for Rare Disorders (NORD)
P.O. Box 8923
(100 Route 37)
New Fairfield, CT 06812-8923
orphan@rarediseases.org
http://www.rarediseases.org/
Tel:
203-746-6518 800-999-NORD (6673)
Fax: 203-746-6481
National Stroke Association
9707 East Easter Lane
Englewood, CO 80112-3747
info@stroke.org
http://www.stroke.org/
Tel:
303-649-9299 800-STROKES (787-6537)
Fax: 303-649-1328
Related NINDS Publications and Information
Multi-infarct dementia
information sheet compiled by the National Institute of Neurological
Disorders and Stroke (NINDS).
Cerebral
arteriosclerosis information sheet compiled by the National Institute of
Neurological Disorders and Stroke (NINDS).
An informational
booklet about stroke compiled by the National Institute of Neurological
Disorders and Stroke (NINDS).
Stroke information sheet
compiled by NINDS.
This fact sheet is in the public domain. You may copy it.Provided
by:
The National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD
20892
Medical Tools & Articles:
Next articles:
Medical Articles:
We subscribe to the HONcode principles.